Implications of new colorectal cancer screening technologies for primary care practice.
Zauber
Ann G
AG
Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA. zaubera@mskcc.org
Levin
Theodore R
TR
Jaffe
C Carl
CC
Galen
Barbara A
BA
Ransohoff
David F
DF
Brown
Martin L
ML
D003106:Colon / Q000000981:diagnostic imaging; D023881:Colonography, Computed Tomographic / Q000379:methods*; D003113:Colonoscopy / Q000379:methods*; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000517:prevention & control*; D004273:DNA, Neoplasm / Q000032:analysis; D005243:Feces / Q000737:chemistry; D006801:Humans; D008403:Mass Screening / Q000379:methods / Q000639:trends*; D009780:Occult Blood; D011320:Primary Health Care / Q000639:trends*; D018570:Risk Assessment / Q000379:methods; D012812:Sigmoidoscopy / Q000379:methods; D014481:United States / Q000453:epidemiology
D004273:DNA, Neoplasm